Back to Search
TERESA LYNCH, M.D.
M.D.
Pediatrics Physician
NPI: 1306042627Individual
Specialties, Licenses & Credentials
Pediatrics PhysicianPrimary
Pediatrics
Code: 208000000X
33005(AL)
Research & Publications (20)
A randomized phase 2 study of erlotinib alone and in combination with bortezomib in previously treated advanced non-small cell lung cancer.
PMID 19633475·J Thorac Oncol·2009
3-trial
Barriers to the development of palliative care in the countries of Central and Eastern Europe and the Commonwealth of Independent States.
PMID 19268812·J Pain Symptom Manage·2009
8-other
Borderline personality disorder and emotional responding: a review of the research literature.
PMID 17544188·Clin Psychol Rev·2008
6-review
Summary statement novel agents in the treatment of lung cancer: Fifth Cambridge Conference assessing opportunities for combination therapy.
PMID 18520291·J Thorac Oncol·2008
8-other
Novel agents in the treatment of lung cancer: Fourth Cambridge Conference.
PMID 17671145·Clin Cancer Res·2007
7-preclinical
A mediational model of trait negative affectivity, dispositional thought suppression, and intrusive thoughts following laboratory stressors.
PMID 16934744·Behav Res Ther·2007
8-other
The effect of cytochrome P450 metabolism on drug response, interactions, and adverse effects.
PMID 17708140·Am Fam Physician·2007
6-review
Dialectical behavior therapy for borderline personality disorder.
PMID 17716053·Annu Rev Clin Psychol·2007
6-review
Treatment of older adults with co-morbid personality disorder and depression: a dialectical behavior therapy approach.
PMID 17096462·Int J Geriatr Psychiatry·2007
2-rct
Epidermal growth factor receptor inhibitor-associated cutaneous toxicities: an evolving paradigm in clinical management.
PMID 17522250·Oncologist·2007
6-review
Incorporation of recreational fishing effort into design of marine protected areas.
PMID 17002764·Conserv Biol·2006
8-other
Heightened sensitivity to facial expressions of emotion in borderline personality disorder.
PMID 17144755·Emotion·2006
8-other
Summary statement: novel agents in the treatment of lung cancer: advances in epidermal growth factor receptor-targeted agents.
PMID 16857812·Clin Cancer Res·2006
7-preclinical
Mechanisms of change in dialectical behavior therapy: theoretical and empirical observations.
PMID 16470714·J Clin Psychol·2006
8-other
Medication costs as a primary cause of nonadherence in the elderly.
PMID 16524358·Consult Pharm·2006
8-other
Optimizing chemotherapy and targeted agent combinations in NSCLC.
PMID 16551519·Lung Cancer·2005
8-other
Optimizing chemotherapy and targeted agent combinations in NSCLC.
PMID 16557671·Lung Cancer·2005
6-review
Early stage lung cancer--new approaches to evaluation and treatment: conference summary statement.
PMID 16000599·Clin Cancer Res·2005
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 245 GOVERNORS DR SE
HUNTSVILLE, AL 35801 - Phone
- (562) 659-8892
Quick Facts
- NPI
- 1306042627
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile